Lv1
48 积分 2024-10-12 加入
Delayed-Release Oral Mesalamine at 4.8 g/day (800 mg tablet) for the Treatment of Moderately Active Ulcerative Colitis: The ASCEND II Trial
1个月前
已完结
Intravenous iron: a framework for changing the management of iron deficiency
1个月前
已完结
Expert consensus on improving iron deficiency anemia management in obstetrics and gynecology in Asia
1个月前
已完结
Iron Deficiency in Adults
1个月前
已完结
Practice Bulletin No. 136
1个月前
已完结
Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency
3个月前
已完结
Iron deficiency anaemia—an ongoing challenge
3个月前
已完结
Evaluating the effects of 5‐aminosalicylic acid on tofacitinib treatment in ulcerative colitis
4个月前
已完结
皖公网安备34019202002308
